CHARACTERIZATION OF A MONOCLONAL ANTI-BETA-2-MICROGLOBULIN ANTIBODY AND ITS USE IN THE GENETIC AND BIOCHEMICAL-ANALYSIS OF MAJOR HISTOCOMPATIBILITY ANTIGENS
CHARACTERIZATION OF A MONOCLONAL ANTI-BETA-2-MICROGLOBULIN ANTIBODY AND ITS USE IN THE GENETIC AND BIOCHEMICAL-ANALYSIS OF MAJOR HISTOCOMPATIBILITY ANTIGENS
复制标题
DOI:
10.1002/eji.1830090709
复制
发表时间:
1979-01-01
影响因子:
5.4
通讯作者:
PARHAM, P
中科院分区:
文献类型:
--
作者:
BRODSKY, FM;BODMER, WF;PARHAM, P
A monoclonal anti-.beta.2-microglobulin (BBM.1 antibody) was produced by cell fusion between the mouse myeloma, P3-X63-Ag8 and spleen cells from a BALB/c mouse immunized with Molt 4, a human [neoplastic] T [thymus-derived] cell line. BBM.1 antibody was fully inhibited by soluble .beta.2-microglobulin and purified HLA-A, B antigens and reacted with human-mouse somatic cell hybrids only if they had chromosome 15 and expressed human .beta.2-microglobulin. It was cytotoxic in complement-dependent lysis and of the Ig[immunoglobulin]G class. BBM.1 and a monoclonal anti-HLA-A, B, C glycoprotein antibody, W6/32, were used to quantitate relative amounts of .beta.2-microglobulin and HLA-A, B, C glycoproteins on different human cell types. Thymocytes and the Molt 4 cell line showed a considerable excess of .beta.2-microglobulin over HLA-A, B, C glycoproteins, as measured by W6/32 reactivity. B [bone marrow-derived] cell lines, peripheral blood lymphocytes, fibroblasts, a HeLa cell derivative and HSB-2, another T cell line, had equal amounts. Immunological cross-reactions between HLA-A, B, C antigens and .beta.2-microglobulin and their homologs in other species were detected with the BBM.1 and W6/32 antibodies. The W6/32 antigenic determinant appeared to be more highly conserved than that recognized by the BBM.1 antibody.